Search

Your search keyword '"Pagadala, Meghana"' showing total 42 results

Search Constraints

Start Over You searched for: Author "Pagadala, Meghana" Remove constraint Author: "Pagadala, Meghana" Search Limiters Available in Library Collection Remove constraint Search Limiters: Available in Library Collection
42 results on '"Pagadala, Meghana"'

Search Results

1. Pre-operative stereotactic radiosurgery and peri-operative dexamethasone for resectable brain metastases: a two-arm pilot study evaluating clinical outcomes and immunological correlates.

2. GRIEVOUS: your command-line general for resolving cross-dataset genotype inconsistencies

3. Agent orange exposure and prostate cancer risk in the million veteran program

4. Germline DNA damage response gene mutations as predictive biomarkers of immune checkpoint inhibitor efficacy

5. Circular extrachromosomal DNA promotes tumor heterogeneity in high-risk medulloblastoma

6. The GPCR–Gαs–PKA signaling axis promotes T cell dysfunction and cancer immunotherapy failure

7. Autoimmune alleles at the major histocompatibility locus modify melanoma susceptibility.

8. Polygenic risk of any, metastatic, and fatal prostate cancer in the Million Veteran Program

9. 3D genome mapping identifies subgroup-specific chromosome conformations and tumor-dependency genes in ependymoma

10. Germline modifiers of the tumor immune microenvironment implicate drivers of cancer risk and immunotherapy response

11. The role of testosterone, the androgen receptor, and hypothalamic-pituitary–gonadal axis in depression in ageing Men

12. PRState: Incorporating genetic ancestry in prostate cancer risk scores for men of African ancestry

13. Accurate genome-wide genotyping from archival tissue to explore the contribution of common genetic variants to pre-cancer outcomes

14. PRState: Incorporating Genetic Ancestry in Prostate Cancer Risk scores for African American Men

15. Non-cancer-related pathogenic germline variants and expression consequences in ten-thousand cancer genomes

16. Germline and Somatic Genetic Variants in the p53 Pathway Interact to Affect Cancer Risk, Progression, and Drug Responsep53 Pathway SNPs and Mutations Interact to Affect Cancer

17. A common polymorphism in the retinoic acid pathway modifies adrenocortical carcinoma age-dependent incidence

18. Agent orange exposure and prostate cancer risk in the million veteran program

19. Prevalence, Morbidity, and Mortality of Men With Sex Chromosome Aneuploidy in the Million Veteran Program Cohort

20. Prevalence, Morbidity, and Mortality of Men With Sex Chromosome Aneuploidy in the Million Veteran Program Cohort

21. Adrenal-Permissive Germline HSD3B1 Allele and Prostate Cancer Outcomes

22. Domain-swapped T cell receptors improve the safety of TCR gene therapy.

23. Using Germline Variation to Study Inter-Individual Variability in Cancer Risk and Host Anti-Tumor Immune Response

24. Polygenic risk of any, metastatic, and fatal prostate cancer in the Million Veteran Program.

26. Germline DNA damage response gene mutations as predictive biomarkers of immune checkpoint inhibitor efficacy.

28. PRState: Incorporating Genetic Ancestry in Prostate Cancer Risk scores for African American Men

29. Germline modifiers of the tumor immune microenvironment implicate drivers of cancer risk and immunotherapy response

30. Agent Orange exposure and prostate cancer risk in the Million Veteran Program

31. Response to Haiman, Kote-Jarai, Darst et al.

32. Polygenic risk of any, metastatic, and fatal prostate cancer in the Million Veteran Program

34. Abstract 3825: Germline modifiers of the tumor immune microenvironment reveal drivers of immunotherapy response

35. EPEN-18. Oncogenic 3D genome conformations identify novel therapeutic targets in ependymoma

36. Additional file 4 of Non-cancer-related pathogenic germline variants and expression consequences in ten-thousand cancer genomes

37. Germline and Somatic Genetic Variants in the p53 Pathway Interact to Affect Cancer Risk, Progression, and Drug Response.

38. EPEN-04. ONCOGENIC 3D TUMOR GENOME ORGANIZATION IDENTIFIES NEW THERAPEUTIC TARGETS IN EPENDYMOMA

40. Germline and somatic genetic variants in the p53 pathway interact to affect cancer risk, progression, and drug response

41. Integrated germline and somatic features reveal divergent immune pathways driving ICB response.

Catalog

Books, media, physical & digital resources